SUPRIYA LIFESCIENCE Financial Statement Analysis
|
||
The Revenues of SUPRIYA LIFESCIENCE have decreased by -13.04% YoY .
The Earnings Per Share (EPS) of SUPRIYA LIFESCIENCE has decreased by -40.83 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SUPRIYA LIFESCIENCE Last 5 Annual Financial Results
[BOM: 543434|NSE : SUPRIYA]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹461 Cr | ₹530 Cr | ₹391 Cr | ₹312 Cr | ₹278 Cr |
Expenses | ₹332 Cr | ₹316 Cr | ₹218 Cr | ₹213 Cr | ₹213 Cr |
Operating Profit (Excl OI) | ₹128 Cr | ₹214 Cr | ₹173 Cr | ₹98 Cr | ₹64 Cr |
Other Income | ₹9.99 Cr | ₹7.58 Cr | ₹5.01 Cr | ₹11 Cr | ₹8.33 Cr |
Interest | ₹3.13 Cr | ₹4.20 Cr | ₹4.08 Cr | ₹6.85 Cr | ₹10 Cr |
Depreciation | ₹12 Cr | ₹10 Cr | ₹6.76 Cr | ₹6.38 Cr | ₹5.44 Cr |
Profit Before Tax | ₹123 Cr | ₹207 Cr | ₹167 Cr | ₹96 Cr | ₹57 Cr |
Profit After Tax | ₹90 Cr | ₹152 Cr | ₹124 Cr | ₹73 Cr | ₹39 Cr |
Consolidated Net Profit | ₹90 Cr | ₹152 Cr | ₹124 Cr | ₹73 Cr | ₹39 Cr |
Earnings Per Share (Rs) | ₹11.16 | ₹18.86 | ₹16.89 | ₹50.15 | ₹26.93 |
PAT Margin (%) | 17.40 | 25.80 | 28.68 | 20.41 | 12.27 |
ROE(%) | 13.66 | 34.34 | 59.17 | 60.42 | 53.11 |
ROCE(%) | 18.72 | 43.34 | 60.12 | 49.67 | 36.52 |
Total Debt/Equity(x) | 0.02 | 0.03 | 0.26 | 0.55 | 0.96 |
Key Financials |
||
Market Cap | : | ₹ 4,791.4 Cr |
Revenue (TTM) | : | ₹ 599.0 Cr |
Net Profit(TTM) | : | ₹ 135.2 Cr |
EPS (TTM) | : | ₹ 16.8 |
P/E (TTM) | : | 35.4 |
Industry Peers & Returns | 1W | 1M | 1Y |
SUPRIYA LIFESCIENCE | 12.1% | 40.6% | 108.9% |
SUN PHARMACEUTICAL INDUSTRIES | 0.4% | 5.1% | 64.6% |
CIPLA | -2.1% | 3.7% | 30.8% |
DR REDDYS LABORATORIES | -2.9% | -3.7% | 20.1% |
ZYDUS LIFESCIENCES | -1% | -13.6% | 81.7% |
DIVIS LABORATORIES | 2.1% | 3.9% | 42.8% |
SUPRIYA LIFESCIENCE Revenues
[BOM: 543434|NSE : SUPRIYA]
Y-o-Y | -13.04 % |
5 Yr CAGR | 13.49 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹461 Cr | -13.04 | |
Mar2022 | ₹530 Cr | 35.49 | |
Mar2021 | ₹391 Cr | 25.53 | |
Mar2020 | ₹312 Cr | 12.17 | |
Mar2019 | ₹278 Cr | - |
SUPRIYA LIFESCIENCE Operating Profit
[BOM: 543434|NSE : SUPRIYA]
Y-o-Y | -39.98 % |
5 Yr CAGR | 18.82 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹128 Cr | -39.98 | |
Mar2022 | ₹214 Cr | 23.59 | |
Mar2021 | ₹173 Cr | 75.99 | |
Mar2020 | ₹98 Cr | 52.69 | |
Mar2019 | ₹64 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -30.96 % |
5 Yr CAGR | 4.70 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 27.87% | -30.96 | |
Mar2022 | 40.37% | -8.79 | |
Mar2021 | 44.26% | 40.20 | |
Mar2020 | 31.57% | 36.14 | |
Mar2019 | 23.19% | - |
SUPRIYA LIFESCIENCE Profit After Tax
[BOM: 543434|NSE : SUPRIYA]
Y-o-Y | -40.81 % |
5 Yr CAGR | 22.87 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹90 Cr | -40.81 | |
Mar2022 | ₹152 Cr | 22.83 | |
Mar2021 | ₹124 Cr | 68.38 | |
Mar2020 | ₹73 Cr | 86.19 | |
Mar2019 | ₹39 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -32.56 % |
5 Yr CAGR | 9.13 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 17.4 % | -32.56 | |
Mar2022 | 25.8 % | -10.04 | |
Mar2021 | 28.68 % | 40.52 | |
Mar2020 | 20.41 % | 66.34 | |
Mar2019 | 12.27 % | - |
SUPRIYA LIFESCIENCE Earnings Per Share (EPS)
[BOM: 543434|NSE : SUPRIYA]
Y-o-Y | -40.83 % |
5 Yr CAGR | -19.77 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹11 | -40.83 | |
Mar2022 | ₹19 | 11.66 | |
Mar2021 | ₹17 | -66.32 | |
Mar2020 | ₹50 | 86.22 | |
Mar2019 | ₹27 | - |
SUPRIYA LIFESCIENCE Return on Capital Employed (ROCE)
[BOM: 543434|NSE : SUPRIYA]
Y-o-Y | -56.81 % |
5 Yr CAGR | -15.39 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 18.72% | -56.81 | |
Mar2022 | 43.34% | -27.91 | |
Mar2021 | 60.12% | 21.04 | |
Mar2020 | 49.67% | 36.01 | |
Mar2019 | 36.52% | - |
SUPRIYA LIFESCIENCE Share Price vs Sensex
Current Share Price | : | ₹595.2 |
Current MarketCap | : | ₹ 4,791.4 Cr |
Updated EOD on | : | Sep 06,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUPRIYA LIFESCIENCE | 12.1% |
40.6% |
108.9% |
SENSEX | -1.4% |
3.3% |
25.2% |
SUPRIYA LIFESCIENCE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 0.7% | 8.6% | 55.8% |
S&P BSE SMALL CAP | -0.1% | 7.6% | 50.7% |
S&P BSE MIDSMALLCAP | -0.6% | 7% | 53.1% |
S&P BSE ALLCAP | -1.1% | 4.7% | 39.1% |
You may also like the below Video Courses
FAQ about SUPRIYA LIFESCIENCE Financials
How the annual revenues of SUPRIYA LIFESCIENCE have changed ?
The Revenues of SUPRIYA LIFESCIENCE have decreased by -13.04% YoY .
How the Earnings per Share (EPS) of SUPRIYA LIFESCIENCE have changed?
The Earnings Per Share (EPS) of SUPRIYA LIFESCIENCE has decreased by -40.83 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs